1
|
Di Natale C, Lucidi L, Montemitro C, Pettorruso M, Collevecchio R, Di Caprio L, Giampietro L, Aceto L, Martinotti G, Giannantonio MD. Gender Differences in the Psychopathology of Obesity: How Relevant Is the Role of Binge Eating Behaviors? Brain Sci 2022; 12:brainsci12070955. [PMID: 35884761 PMCID: PMC9321462 DOI: 10.3390/brainsci12070955] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2022] [Revised: 07/15/2022] [Accepted: 07/19/2022] [Indexed: 12/10/2022] Open
Abstract
Background: Obesity is a condition that affects humans both physically and mentally. Moreover, many psychopathological conditions can be observed in obese patients that may threaten the positive outcomes of bariatric surgery. Purpose: The aim of this study was to identify the main psychopathological correlates of obese candidates for bariatric surgery, with particular attention on the relationship between psychopathology and gender. Methods: In total, 273 candidates for bariatric surgery for obesity underwent a psychiatric evaluation using a compilation of psychometric scales: the Revised Symptom Checklist 90-R (SCL-90-R), the Eating Disorder Examination Questionnaire (EDE-Q), the Binge Eating Scale (BES), the Body Uneasiness Test (BUT) and the Obesity-Related Well-Being (ORWELL 97). The sample was divided on the basis of gender and binge eating disorder (BED) severity. Comparisons between the groups were performed using an analysis of variance model (ANOVA) or a Pearson’s chi-squared test. Further, we also divided our sample into a severe binge eating group (score > 27), a mild to moderate group (18 < score < 26) and a low/no symptoms group (score < 17). Results: Male and female subjects showed different results for the BES, with higher scores reported among women (17.50 ± 9.59) compared to men (14.08 ± 8.64). Women also showed higher scores across most of the SCL-90-R domains and worse outcomes in terms of quality of life. Both women and men in the severe binge eating group reported higher scores for the SCL-90-R. Conclusion: The symptoms of BED, along with body image dissatisfaction (BID), are among the most important to investigate for candidates for bariatric surgery in order to improve the surgery outcomes. Level of evidence: Level III as the evidence came from a cohort analytic study.
Collapse
Affiliation(s)
- Chiara Di Natale
- Department of Neuroscience, Imaging and Clinical Sciences, “G. d’Annunzio” University, 66100 Chieti, Italy; (C.D.N.); (C.M.); (M.P.); (R.C.); (G.M.); (M.d.G.)
| | - Lorenza Lucidi
- Department of Neuroscience, Imaging and Clinical Sciences, “G. d’Annunzio” University, 66100 Chieti, Italy; (C.D.N.); (C.M.); (M.P.); (R.C.); (G.M.); (M.d.G.)
- Correspondence:
| | - Chiara Montemitro
- Department of Neuroscience, Imaging and Clinical Sciences, “G. d’Annunzio” University, 66100 Chieti, Italy; (C.D.N.); (C.M.); (M.P.); (R.C.); (G.M.); (M.d.G.)
| | - Mauro Pettorruso
- Department of Neuroscience, Imaging and Clinical Sciences, “G. d’Annunzio” University, 66100 Chieti, Italy; (C.D.N.); (C.M.); (M.P.); (R.C.); (G.M.); (M.d.G.)
| | - Rebecca Collevecchio
- Department of Neuroscience, Imaging and Clinical Sciences, “G. d’Annunzio” University, 66100 Chieti, Italy; (C.D.N.); (C.M.); (M.P.); (R.C.); (G.M.); (M.d.G.)
| | - Lucia Di Caprio
- Psychiatry Department, Madonna del Soccorso Hospital, 63074 San Benedetto del Tronto, Italy;
| | - Luana Giampietro
- Psychiatry Department, SS. Annunziata Hospital, 66100 Chieti, Italy;
| | - Liberato Aceto
- Obesity Surgery Center, SS. Annunziata Hospital, 66100 Chieti, Italy;
| | - Giovanni Martinotti
- Department of Neuroscience, Imaging and Clinical Sciences, “G. d’Annunzio” University, 66100 Chieti, Italy; (C.D.N.); (C.M.); (M.P.); (R.C.); (G.M.); (M.d.G.)
- Department of Clinical and Pharmaceutical Sciences, University of Hertfordshire, Hatfield AL10, UK
| | - Massimo di Giannantonio
- Department of Neuroscience, Imaging and Clinical Sciences, “G. d’Annunzio” University, 66100 Chieti, Italy; (C.D.N.); (C.M.); (M.P.); (R.C.); (G.M.); (M.d.G.)
| |
Collapse
|
2
|
Effect of COVID-19 Lockdowns on Physical Activity, Eating Behavior, Body Weight and Psychological Outcomes in a Post-Bariatric Cohort. Obes Surg 2022; 32:1-9. [PMID: 35486289 PMCID: PMC9051813 DOI: 10.1007/s11695-022-06069-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2021] [Revised: 04/13/2022] [Accepted: 04/13/2022] [Indexed: 01/23/2023]
Abstract
PURPOSE Little is known about the consequences of COVID-19 lockdowns on physical activity (PA), eating behavior, and mental health in post-bariatric surgery (BS) patients. We aimed to analyze the relations between changes in PA during COVID-19 lockdowns and changes in body weight and a comprehensive set of lifestyle and psychological outcomes in patients who have undergone BS. MATERIAL AND METHODS In April-May 2020 (lockdown#1), we performed an online survey in a cohort of 937 adults who underwent BS and were followed-up at our university medical center for at least one year. We assessed changes in PA, eating behavior, body weight, fatigue, and depression (PHQ-9). In November-December 2020 (lockdown#2), we recorded body weight in 280 patients who had reported decreased PA during lockdown #1. RESULTS During lockdown #1 (N = 420 patients included, 44% response rate), decreased PA was reported by 67% patients. Compared to those who reported increased or unchanged PA, patients with decreased PA were more likely to report a ≥ 5% weight gain (OR (95% CI): 3.15 (1.46-7.65), increased fatigue (2.08 (1.36-3.23)), a worsening of eating behavior (2.29 (1.47-3.58)), and moderate-to-severe depressive symptoms (4.74 (2.14-11.76)). During lockdown #2 (N = 225 patients, 80% response rate), significant weight gain since before lockdown #1 was reported (+ 2.8 (95% CI: 1.7-3.8) kg, p < 0.001), with 36% patients reporting a ≥ 5% weight gain. CONCLUSIONS PA may counteract detrimental effects of COVID-19 lockdown on post-BS weight trajectories and mental health outcomes. Follow-up measures are needed in this setting to assess the long-term impact of lockdown.
Collapse
|
3
|
The Impact of the COVID-19 Pandemic on Patients from a Bariatric Program: A Qualitative Analysis of Their Perceptions of Health and Well-Being. Healthcare (Basel) 2022; 10:healthcare10050780. [PMID: 35627916 PMCID: PMC9141578 DOI: 10.3390/healthcare10050780] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2022] [Revised: 04/12/2022] [Accepted: 04/14/2022] [Indexed: 11/17/2022] Open
Abstract
Introduction: The study was conducted to explore the perceptions of patients from a bariatric program who have undergone or will undergo bariatric surgery during the ongoing COVID-19 pandemic, specifically as related to their struggles with health issues and their psychological well-being. Materials and Methods: We conducted semi-structured, in-depth interviews with nineteen pre- or post-bariatric patients to generate data on their perceptions of COVID-19. Consistent with the methods of constructivist grounded theory, we collected and analyzed data iteratively through a constant comparative process for data coding and develop themes in the transcripts. Results: We identified themes to summarize the pandemic-associated experiences of our cohort as follows: their life structure before COVID-19, the turning point with changes and adaptations, and the impact of isolation on psychological well-being. We identified grief due to loss of social contacts as well as physical and psychological health impairment as consequences of pandemic-related lifestyle changes. Most participants were not aware of overweight and obesity being major risk factors for worse outcomes of COVID-19. We developed a theme-based theory on patients’ perceptions and fears regarding the pandemic as they live through phases of grief. Discussion: Most participants shared critical perceptions about their own somatic and psychological health. These findings may inform recommendations and strategies for both patients and healthcare professionals to manage the challenges potentially presented by this vulnerable patient group in the context of the COVID-19 pandemic.
Collapse
|
4
|
Blanchard C, Perennec T, Smati S, Tramunt B, Guyomarch B, Bigot‐Corbel E, Bordier L, Borot S, Bourron O, Caussy C, Coffin‐Boutreux C, Dutour A, Germain N, Gonfroy‐Leymarie C, Meyer L, Prevost G, Roussel R, Seret‐Bégué D, Thivolet C, Vergès B, Pichelin M, Gourdy P, Hadjadj S, Wargny M, Pattou F, Cariou B. History of bariatric surgery and COVID-19 outcomes in patients with type 2 diabetes: Results from the CORONADO study. Obesity (Silver Spring) 2022; 30:599-605. [PMID: 34586754 PMCID: PMC8661775 DOI: 10.1002/oby.23314] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/16/2021] [Revised: 08/22/2021] [Accepted: 09/16/2021] [Indexed: 12/01/2022]
Abstract
OBJECTIVE This study assessed the impact of a history of metabolic and bariatric surgery (MBS) on the clinical outcomes in patients with type 2 diabetes (T2D) and severe obesity hospitalized for COVID-19. METHODS In this post hoc analysis from the nationwide observational CORONADO (Coronavirus SARS-CoV2 and Diabetes Outcomes) study, patients with T2D and a history of MBS were matched with patients without MBS for age, sex, and BMI either at the time of MBS or on admission for COVID-19. The composite primary outcome (CPO) combined invasive mechanical ventilation and/or death within 7 and 28 days following admission. RESULTS Out of 2,398 CORONADO participants, 20 had a history of MBS. When matching for BMI at the time of MBS and after adjustment for diabetes duration, the CPO occurred less frequently within 7 days (3 vs. 17 events, OR: 0.15 [0.01 to 0.94], p = 0.03) and 28 days (3 vs. 19 events, OR: 0.11 [0.01 to 0.71], p = 0.02) in patients with MBS (n = 16) vs. controls (n = 44). There was no difference in CPO rate between patients with MBS and controls when matching for BMI on admission. CONCLUSIONS These data are reassuring regarding COVID-19 prognosis in patients with diabetes and a history of MBS compared with those without MBS.
Collapse
Affiliation(s)
- Claire Blanchard
- Université de NantesCHU NantesCNRSINSERM, l’institut Du ThoraxNantesFrance
- Chirurgie Cancérologique Digestive et Endocrinienne (CCDE)Institut des Maladies de l’Appareil Digestif (IMAD)Centre Hospitalo‐universitaire de Nantes (CHU) Hôtel‐DieuNantesFrance
| | - Tanguy Perennec
- CHU de NantesINSERM CIC 1413Pôle Hospitalo‐Universitaire 11 : Santé Publique, Clinique des donnéesNantesFrance
| | - Sarra Smati
- Université de NantesCHU NantesCNRSINSERM, l’institut Du ThoraxNantesFrance
| | - Blandine Tramunt
- Département d’EndocrinologieDiabétologie et NutritionCHU ToulouseInstitut des Maladies Métaboliques et CardiovasculairesUMR1297 INSERM/UPSUniversité de ToulouseToulouseFrance
| | - Béatrice Guyomarch
- Université de NantesCHU NantesCNRSINSERM, l’institut Du ThoraxNantesFrance
| | | | - Lyse Bordier
- Hôpital d'instruction des Armées BéginSaint MandéFrance
| | - Sophie Borot
- Département d'EndocrinologieDiabétologie et NutritionCHU de BesançonBesançonFrance
| | - Olivier Bourron
- Département de DiabétologieCHU La Pitié Salpêtrière‐Charles FoixInsermUMR_S 1138Centre de Recherche des CordeliersParis 06Institute of Cardiometabolism and Nutrition ICANSorbonne UniversitéAssistance Publique–Hôpitaux de ParisParisFrance
| | - Cyrielle Caussy
- Univ‐Lyonlaboratoire CarMeNInserm U1060INRA U1397Université Claude Bernard Lyon 1INSA LyonVilleurbanneFrance
- Département EndocrinologieDiabète et NutritionHospices Civils de LyonHôpital Lyon SudPierre‐BéniteFrance
| | | | - Anne Dutour
- Aix Marseille UnivAPHMINSERMINRAEC2VNHôpital Nord Département d’Endocrinologie et de DiabétologieMarseilleFrance
| | - Natacha Germain
- Département d’EndocrinologieCHU de Saint‐EtienneSaint‐EtienneFrance
- Laboratoire TAPEEating desorders, Addiction and Extreme bodyweightUniversité Jean MonnetSaint‐EtienneFrance
| | | | - Laurent Meyer
- Département d’EndocrinologieDiabétologie et NutritionHôpitaux Universitaires de StrasbourgStrasbourgFrance
| | - Gaëtan Prevost
- Département d’EndocrinologieDiabète et Maladies MétaboliquesNormandie UnivUNIROUEN, CHU de RouenRouenFrance
| | - Ronan Roussel
- Département d’EndocrinologieDiabétologie et NutritionHôpital BichatAssistance Publique–Hôpitaux de ParisCentre de Recherche des CordeliersINSERMU‐1138Université de ParisParisFrance
| | | | | | - Bruno Vergès
- Service EndocrinologieDiabétologie et Maladies MétaboliquesHôpital du BocageDijonFrance
| | - Matthieu Pichelin
- Université de NantesCHU NantesCNRSINSERM, l’institut Du ThoraxNantesFrance
| | - Pierre Gourdy
- Département d’EndocrinologieDiabétologie et NutritionCHU ToulouseInstitut des Maladies Métaboliques et CardiovasculairesUMR1297 INSERM/UPSUniversité de ToulouseToulouseFrance
| | - Samy Hadjadj
- Université de NantesCHU NantesCNRSINSERM, l’institut Du ThoraxNantesFrance
| | - Matthieu Wargny
- Université de NantesCHU NantesCNRSINSERM, l’institut Du ThoraxNantesFrance
- CHU de NantesINSERM CIC 1413Pôle Hospitalo‐Universitaire 11 : Santé Publique, Clinique des donnéesNantesFrance
| | - François Pattou
- Univ LilleInserm, CHU LilleInstitut Pasteur de LilleEuropean Genomic Institute of DiabetesChirurge Endocrinienne et MétaboliqueCente Intégré de l’ObésitéLilleFrance
| | - Bertrand Cariou
- Université de NantesCHU NantesCNRSINSERM, l’institut Du ThoraxNantesFrance
| | | |
Collapse
|
5
|
Strong H, Reiter-Purtill J, Howarth T, West-Smith L, Zeller MH. Early COVID-19 Vaccine Hesitancy Characteristics in Mothers Following Bariatric Surgery. Obes Surg 2022; 32:852-860. [PMID: 34997432 PMCID: PMC8741570 DOI: 10.1007/s11695-021-05872-2] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2021] [Revised: 12/24/2021] [Accepted: 12/29/2021] [Indexed: 01/22/2023]
Abstract
BACKGROUND Obesity has played a central role in heightened coronavirus disease 2019 (COVID-19) risk and vaccine response. COVID-19 vaccine intention among those with a history of severe obesity, specifically those who have undergone bariatric surgery, has not been described. This study aims to examine early COVID-19 vaccine intention among mothers with a history of severe obesity who underwent bariatric surgery. METHODS Sixty-four mothers (Mage = 39.3 years) who underwent bariatric surgery (Mtime since surgery = 19.6 months) completed surveys online (November 2020-February 2021). Information obtained included their COVID-19 vaccine intention (vaccine ready, undecided, vaccine opposed). Analyses examined group differences in demographics, body mass index (BMI = kg/m2), knowledge of obesity-related COVID-19 risk, flu vaccination history, general beliefs about vaccine safety/effectiveness, and factors increasing confidence/motivation to obtain a COVID-19 vaccine. RESULTS Thirty-six (56.3%) mothers had severe obesity (≥ Class II [BMI = ≥ 35 kg/m2]). The majority were vaccine hesitant (undecided [n = 28; 43.8%]; vaccine opposed [n = 15; 23.4%]). Compared to the vaccine-ready group, vaccine-hesitant groups were younger (p < .05). For the vaccine opposed, recent flu vaccination rates (p = .012) and general belief that vaccines are safe (p = .028) were lower than expected. Among hesitant participants, no reported side effects and the health of self and others were endorsed as top factors increasing vaccine confidence and motivation respectively. CONCLUSIONS While preliminary, the prominence of early vaccine hesitancy in this sample of mothers who have undergone bariatric surgery, with most persisting with severe obesity, indicates a subgroup at high risk. Factors to address through targeted messaging and intervention were identified.
Collapse
Affiliation(s)
- Heather Strong
- Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA.
| | - Jennifer Reiter-Purtill
- Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA
| | - Taylor Howarth
- Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA
| | - Lisa West-Smith
- Department of Psychiatry and Behavioral Neuroscience & Department of Surgery, University of Cincinnati College of Medicine, 3230 Eden Avenue, Cincinnati, OH, 45267, USA
| | - Meg H Zeller
- Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA
- Department of Pediatrics, University of Cincinnati College of Medicine, 3230 Eden Avenue, Cincinnati, OH, 45267, USA
| |
Collapse
|
6
|
Costa LHSDM, Costa LFSDM, Kachan GR, Gentile JKDA, Mendonça RA, Costa MRDCD, Ribas JM. The impact of bariatric and metabolic surgery on the morbidity and mortality of patients infected during the COVID-19 pandemic: a retrospective cohort study. SAO PAULO MED J 2022; 141:120-124. [PMID: 36043675 PMCID: PMC10005465 DOI: 10.1590/1516-3180.2021.0952.r2.11052022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/14/2022] [Accepted: 05/11/2022] [Indexed: 12/23/2022] Open
Abstract
BACKGROUND Since the impact of the coronavirus disease 2019 (COVID-19) pandemic in March 2020, several studies have shown a strong relationship between obesity and severe cases of COVID-19. It is imperative to assess whether bariatric surgery exerts a protective effect in such cases. OBJECTIVE This study aimed to assess the impact of bariatric surgery on the morbidity and mortality in obese patients during the COVID-19 pandemic. A comprehensive search was performed using the PubMed and Cochrane Library databases. DESIGN AND SETTING Retrospective cohort studies conducted in the Faculdade de Medicina da Universidade Cidade de São Paulo, São Paulo (SP), Brazil. METHODS The search comprised the following descriptors: "bariatric, surgery, COVID-19". Current retrospective cohort studies that examined the influence of bariatric surgery on the morbidity and mortality of obese patients during the COVID-19 pandemic were considered eligible. RESULTS After removing duplicates, 184 studies were obtained from the databases. Of these, 181 were excluded from the analysis as they did not meet the eligibility criteria. Patients undergoing postoperative follow-up of bariatric surgery had a similar probability of SARS-CoV-2 infection compared to the general population, and persistent comorbidities were associated with an increased risk and severity of infection. CONCLUSION Bariatric surgery has a protective effect against severe COVID-19 in the obese population, bringing the prevalence of severe disease cases to levels equivalent to those of the nonobese general population, with a positive impact on morbidity and mortality.
Collapse
Affiliation(s)
- Luiz Henrique Sala de Melo Costa
- MD. Physician and General Surgeon, Postgraduate Program in
Digestive Tract Surgery, Colégio Brasileiro de Cirurgia Digestiva (CBCD),
Aracaju (SE), Brazil
| | - Luiz Filipe Sala de Melo Costa
- Undergraduate Student of Medical Sciences, Faculdade de
Medicina-Universidade Cidade de São Paulo (FM-UNICID), São Paulo (SP),
Brazil
| | - Gabriela Rezende Kachan
- MD. Physician, Department of Medicine, Faculdade de
Medicina-Universidade Cidade de São Paulo (FM-UNICID), São Paulo (SP),
Brazil
| | - João Kleber de Almeida Gentile
- MD. Gastrosurgeon, General Surgeon, Doctoral Student, and
Assistant Professor, Department of Surgery, Faculdade de Medicina-Universidade
Cidade de São Paulo (FM-UNICID), São Paulo (SP), Brazil
| | - Raul Andrade Mendonça
- MD. Gastrosurgeon and General Surgeon, Department of Urgency of
Hospital de Urgências de Aracajú, Aracaju (SE), Brazil
| | | | - Jurandir Marcondes Ribas
- PhD. Physician and General Surgeon, Department of Digestive
Surgery, Universidade Federal do Paraná (UFRP), Curitina (PR), Brazil
| |
Collapse
|
7
|
Moradpour G, Amini M, Moeinvaziri N, Hosseini SV, Rajabi S, Clark CCT, Hosseini B, Vafa L, Haghighat N. Bariatric Surgery and COVID-19: What We Have Learned from the Pandemic in Iran: a Retrospective Observational Cohort Study. Obes Surg 2022; 32:18-25. [PMID: 34716898 PMCID: PMC8556836 DOI: 10.1007/s11695-021-05761-8] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2021] [Revised: 10/10/2021] [Accepted: 10/18/2021] [Indexed: 12/24/2022]
Abstract
PURPOSE Little is known about the symptoms of coronavirus disease 2019 (COVID-19) on patients with morbid obesity following bariatric surgery (BS) in Iran. Thus, we sought to investigate the symptoms and effect of COVID-19 in patients with morbid obesity following, or candidates for, BS in Iran. MATERIALS AND METHODS In this retrospective observational cohort study, we enrolled 236 morbid obese patients following (surgical group) or candidates (nonsurgical group) for bariatric surgery. Demographics, probable COVID-19 incidence, acute and persistent COVID-19 symptoms, and clinical outcome parameters of bariatric patients and candidates for BS were compared. The incidence of probable COVID-19 was assessed including the clinical definition of probable case, according to World Health Organization criteria. RESULTS The incidence of probable COVID-19 among surgical and nonsurgical groups was significantly different (20.6% vs 26.08%, respectively, p = 0.046). The probable case of surgical patients had a shorter length of symptoms and hospitalization duration, and a lower proportion of admission in ICUs and hospitals with respect to nonsurgical patients (p < 0.001). Surgical patients had a greater prevalence of persistent symptoms including anorexia, food intolerance, and anosmia-hyposmia than nonsurgical patients. Moreover, surgical patients with probable COVID-19 had a significantly higher proportion of diabetic patients than surgical patients without probable COVID-19 (20% vs 9.3%). CONCLUSION These findings highlight the need to evaluate the persistent symptoms of COVID-19 and the importance of nutritional support for at least several weeks after COVID-19 symptom onset. Moreover, it seems that COVID-19 incidence in post-bariatric surgery patients could reduce the effectiveness of bariatric surgery in the resolution of diabetes.
Collapse
Affiliation(s)
- Gholamreza Moradpour
- laparoscopy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Masoud Amini
- laparoscopy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Nader Moeinvaziri
- laparoscopy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Seyed Vahid Hosseini
- laparoscopy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Shirin Rajabi
- laparoscopy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Cain C T Clark
- Centre for Intelligent Healthcare, Coventry University, Coventry, CV1 5FB, UK
| | - Babak Hosseini
- laparoscopy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Leila Vafa
- laparoscopy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Neda Haghighat
- laparoscopy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
| |
Collapse
|
8
|
Abstract
Since it was discovered at the end of 2019; the pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has made a serious public health threat worldwide, with over 175 million confirmed cases reported globally. Even when COVID-19 was initially considered a respiratory disease, it was actually known to be multisystemic, with gastrointestinal involvement a common clinical finding. Furthermore, COVID-19 may affect patients with gastrointestinal comorbidities, being the clinical intersectionality of utmost interest for gastroenterologists; critical care physicians and all the healthcare team taking care of COVID-19 patients. The present article presents a brief review of the reported gastrointestinal manifestations of COVID-19 disease in both previously healthy individuals and in patients with gastrointestinal comorbidities.
Collapse
|
9
|
Rogers AM. Comment on: Outcomes of obese patients hospitalized with COVID-19: the impact of prior bariatric surgery. Surg Obes Relat Dis 2021; 18:40-41. [PMID: 34666949 PMCID: PMC8481121 DOI: 10.1016/j.soard.2021.09.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2021] [Accepted: 09/24/2021] [Indexed: 11/26/2022]
Affiliation(s)
- Ann M Rogers
- College of Medicine, Department of Surgery, Pennsylvania State University, Hershey, Pennsylvania
| |
Collapse
|
10
|
Marchesi F, Valente M, Riccò M, Rottoli M, Baldini E, Mecheri F, Bonilauri S, Boschi S, Bernante P, Sciannamea A, Rolla J, Francescato A, Bollino R, Cartelli C, Lanaia A, Anzolin F, Del Rio P, Fabbi D, Petracca GL, Tartamella F, Dalmonte G. Effects of Bariatric Surgery on COVID-19: a Multicentric Study from a High Incidence Area. Obes Surg 2021; 31:2477-2488. [PMID: 33417099 PMCID: PMC7791147 DOI: 10.1007/s11695-020-05193-w] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2020] [Revised: 12/01/2020] [Accepted: 12/09/2020] [Indexed: 02/07/2023]
Abstract
INTRODUCTION The favorable effects of bariatric surgery (BS) on overall pulmonary function and obesity-related comorbidities could influence SARS-CoV-2 clinical expression. This has been investigated comparing COVID-19 incidence and clinical course between a cohort of patients submitted to BS and a cohort of candidates for BS during the spring outbreak in Italy. MATERIALS AND METHODS From April to August 2020, 594 patients from 6 major bariatric centers in Emilia-Romagna were administered an 87-item telephonic questionnaire. Demographics, COVID-19 incidence, suggestive symptoms, and clinical outcome parameters of operated patients and candidates to BS were compared. The incidence of symptomatic COVID-19 was assessed including the clinical definition of probable case, according to World Health Organization criteria. RESULTS Three hundred fifty-three operated patients (Op) and 169 candidates for BS (C) were finally included in the statistical analysis. While COVID-19 incidence confirmed by laboratory tests was similar in the two groups (5.7% vs 5.9%), lower incidence of most of COVID-19-related symptoms, such as anosmia (p: 0.046), dysgeusia (p: 0.049), fever with rapid onset (p: 0.046) were recorded among Op patients, resulting in a lower rate of probable cases (14.4% vs 23.7%; p: 0.009). Hospitalization was more frequent in C patients (2.4% vs 0.3%, p: 0.02). One death in each group was reported (0.3% vs 0.6%). Previous pneumonia and malignancies resulted to be associated with symptomatic COVID-19 at univariate and multivariate analysis. CONCLUSION Patients submitted to BS seem to develop less severe SARS-CoV-2 infection than subjects suffering from obesity.
Collapse
Affiliation(s)
- Federico Marchesi
- Unit of General Surgery, Parma University Hospital, Parma, Italy.
- Università degli Studi di Parma, Via Gramsci, 14-43126, Parma, Italy.
| | - Marina Valente
- Unit of General Surgery, Parma University Hospital, Parma, Italy
| | - Matteo Riccò
- Dipartimento di Sanità Pubblica/Public Health, AUSL-IRCCS Tecnologie Avanzate e Modelli Assistenziali in Oncologia di Reggio Emilia, Reggio Emilia, Italy
| | - Matteo Rottoli
- Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, Bologna, Italy
- Centre for the Study and Research of Treatment for Morbid Obesity, Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy
| | - Edoardo Baldini
- Department of Surgery, Ospedale "Guglielmo da Saliceto", Piacenza, Italy
| | - Fouzia Mecheri
- Division of General, Emergency Surgery and New Technologies, OCSAE (Ospedale Civile Sant'Agostino Estense), Baggiovara, Modena, Italy
| | - Stefano Bonilauri
- General and Emergency Surgery Unit, Arcispedale Santa Maria Nuova di Reggio Emilia, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy
| | - Sergio Boschi
- Programma Dipartimentale Chirurgia Malassorbitiva AUSL di Bologna, Bologna, Italy
| | - Paolo Bernante
- Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, Bologna, Italy
- Centre for the Study and Research of Treatment for Morbid Obesity, Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy
| | - Andrea Sciannamea
- Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, Bologna, Italy
| | - Jessica Rolla
- Department of Medicine, Ospedale "Guglielmo da Saliceto", Piacenza, Italy
| | - Alice Francescato
- Division of General, Emergency Surgery and New Technologies, OCSAE (Ospedale Civile Sant'Agostino Estense), Baggiovara, Modena, Italy
| | - Ruggero Bollino
- General and Emergency Surgery Unit, Arcispedale Santa Maria Nuova di Reggio Emilia, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy
| | - Concetto Cartelli
- General and Emergency Surgery Unit, Arcispedale Santa Maria Nuova di Reggio Emilia, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy
| | - Andrea Lanaia
- General and Emergency Surgery Unit, Arcispedale Santa Maria Nuova di Reggio Emilia, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy
| | - Francesca Anzolin
- Medical Department, Clinical Nutrition Unit, Maggiore-Bentivoglio Hospital, Ausl Bologna, Bologna, Italy
| | - Paolo Del Rio
- Unit of General Surgery, Parma University Hospital, Parma, Italy
| | - Diletta Fabbi
- Department of Medicine and Surgery, University of Parma, Parma, Italy
| | | | | | - Giorgio Dalmonte
- Unit of General Surgery, Parma University Hospital, Parma, Italy
| |
Collapse
|
11
|
Poghosyan T, Rives-Lange C, Carette C, Girardeau Y, Jannot AS, Czernichow S. Time of Bariatric Surgery and Hospitalization for SARS-CoV-2: a Nationwide Study. Obes Surg 2021; 31:3893-3895. [PMID: 33934296 PMCID: PMC8088484 DOI: 10.1007/s11695-021-05449-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2021] [Revised: 04/21/2021] [Accepted: 04/22/2021] [Indexed: 11/25/2022]
Affiliation(s)
- Tigran Poghosyan
- Université de Paris, F-75015, Paris, France. .,Assistance Publique-Hôpitaux de Paris (AP-HP), Service de Chirurgie Digestive, Oncologique et Bariatrique, Centre Spécialisé Obésité, Hôpital Européen Georges Pompidou, 20 rue Leblanc, 75015, Paris, France. .,INSERM, UMRS 1149 Centre de Recherche sur l'Inflammation, Paris Montmartre, Paris, France.
| | - Claire Rives-Lange
- Université de Paris, F-75015, Paris, France.,Assistance Publique-Hôpitaux de Paris (AP-HP), Service de Nutrition, Centre Spécialisé Obésité, Hôpital Européen Georges Pompidou, Paris, France.,INSERM, UMR 1153, Centre de Recherche Épidémiologie et Statistique Sorbonne Paris Cité, Paris, France
| | - Claire Carette
- Université de Paris, F-75015, Paris, France.,Assistance Publique-Hôpitaux de Paris (AP-HP), Service de Nutrition, Centre Spécialisé Obésité, Hôpital Européen Georges Pompidou, Paris, France
| | - Yannick Girardeau
- Assistance Publique-Hôpitaux de Paris (AP-HP), Service d'informatique médicale, biostatistiques et santé publique, Hôpital Européen Georges Pompidou, Paris, France
| | - Anne-Sophie Jannot
- Université de Paris, F-75015, Paris, France.,Assistance Publique-Hôpitaux de Paris (AP-HP), Service d'informatique médicale, biostatistiques et santé publique, Hôpital Européen Georges Pompidou, Paris, France.,INSERM, Cordeliers Research Center, Information sciences to support personalized medicine, Paris, France
| | - Sebastien Czernichow
- Université de Paris, F-75015, Paris, France.,Assistance Publique-Hôpitaux de Paris (AP-HP), Service de Nutrition, Centre Spécialisé Obésité, Hôpital Européen Georges Pompidou, Paris, France.,INSERM, UMR 1153, Centre de Recherche Épidémiologie et Statistique Sorbonne Paris Cité, Paris, France
| |
Collapse
|
12
|
Caussy C. Obésité et infection par la COVID-19 : une liaison dangereuse. MÉDECINE DES MALADIES MÉTABOLIQUES 2021. [PMCID: PMC7881725 DOI: 10.1016/j.mmm.2021.02.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
|
13
|
O’Rourke RW, Lumeng CN. Pathways to Severe COVID-19 for People with Obesity. Obesity (Silver Spring) 2021; 29:645-653. [PMID: 33270351 PMCID: PMC7753541 DOI: 10.1002/oby.23099] [Citation(s) in RCA: 25] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/27/2020] [Revised: 12/01/2020] [Accepted: 12/01/2020] [Indexed: 12/13/2022]
Abstract
Increased morbidity and mortality from coronavirus disease 2019 (COVID-19) in people with obesity have illuminated the intersection of obesity with impaired responses to infections. Although data on mechanisms by which COVID-19 impacts health are being rapidly generated, there is a critical need to better understand the pulmonary, vascular, metabolic, and immunologic aspects that drive the increased risk for complications from COVID-19 in people with obesity. This review provides a broad overview of the intersection between COVID-19 and the physiology of obesity in order to highlight potential mechanisms by which COVID-19 disease severity is increased by obesity and identify areas for future investigation toward developing tailored therapy for people with obesity who develop COVID-19.
Collapse
Affiliation(s)
- Robert W. O’Rourke
- Department of SurgeryUniversity of Michigan Medical SchoolAnn ArborMichiganUSA
- Department of SurgeryAnn Arbor Veterans Affairs Healthcare SystemAnn ArborMichiganUSA
| | - Carey N. Lumeng
- Division of Pediatric PulmonologyDepartment of PediatricsUniversity of Michigan Medical SchoolAnn ArborMichiganUSA
- Department of Molecular and Integrative PhysiologyUniversity of Michigan Medical SchoolAnn ArborMichiganUSA
| |
Collapse
|
14
|
De Groot CJ, Poitou Bernert C, Coupaye M, Clement K, Paschou SA, Charmandari E, Kanaka-Gantenbein C, Wabitsch M, Buddingh EP, Nieuwenhuijsen B, Marina L, Johannsson G, Van Den Akker ELT. Clinical management of patients with genetic obesity during COVID-19 pandemic: position paper of the ESE Growth & Genetic Obesity COVID-19 Study Group and Rare Endo-ERN main thematic group on Growth and Obesity. Endocrine 2021; 71:653-662. [PMID: 33512658 PMCID: PMC7845285 DOI: 10.1007/s12020-021-02619-y] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/27/2020] [Accepted: 01/08/2021] [Indexed: 12/13/2022]
Abstract
This article aims to provide guidance on prevention and treatment of COVID-19 in patients with genetic obesity. Key principals of the management of patients with genetic obesity during COVID-19 pandemic for patients that have contracted COVID-19 are to be aware of: possible adrenal insufficiency (e.g., POMC deficiency, PWS); a more severe course in patients with concomitant immunodeficiency (e.g., LEP and LEPR deficiency), although defective leptin signalling could also be protective against the pro-inflammatory phenotype of COVID-19; disease severity being masked by insufficient awareness of symptoms in syndromic obesity patients with intellectual deficit (in particular PWS); to adjust medication dose to increased body size, preferably use dosing in m2; the high risk of malnutrition in patients with Sars-Cov2 infection, even in case of obesity. Key principals of the obesity management during the pandemic are to strive for optimal obesity management and a healthy lifestyle within the possibilities of the regulations to prevent weight (re)gain and to address anxiety within consultations, since prevalence of anxiety for COVID-19 is underestimated.
Collapse
Affiliation(s)
- Cornelis Jan De Groot
- Pediatric Endocrinology and Obesity Center CGG Erasmus MC, Rotterdam and Willem Alexander Children's Hospital, LUMC, Leiden, the Netherlands.
| | - Christine Poitou Bernert
- Assistance Publique-Hôpitaux de Paris, Reference Center for Rare Diseases (PRADORT, Prader-Willi Syndrome and other rare obesities), Nutrition Department, Pitié-Salpêtrière hospital, Paris, France
- Sorbonne Université/INSERM, Nutrition and obesities; systemic approaches (NutriOmics) research Unit, Paris, France
| | - Muriel Coupaye
- Assistance Publique-Hôpitaux de Paris, Reference Center for Rare Diseases (PRADORT, Prader-Willi Syndrome and other rare obesities), Nutrition Department, Pitié-Salpêtrière and Louis-Mourier hospitals, Paris, France
| | - Karine Clement
- Sorbonne Université/INSERM, Nutrition and obesities; systemic approaches (NutriOmics) research Unit, Paris, France
- Assistance Publique-Hopitaux de Paris, Nutrition Department, Pitie-Salpetriere Hospital, Paris, France
| | - Stavroula A Paschou
- Division of Endocrinology, Diabetes and Metabolism, Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
| | - Evangelia Charmandari
- Pediatric and Adolescent Endocrinology, National and Kapodistrian University of Athens Medical School, "Aghia Sophia" Children's Hospital, Athens, Greece
- Division of Endocrinology, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, 11527, Greece
| | - Christina Kanaka-Gantenbein
- Division of Endocrinology, Diabetes and Metabolism, First Department of Pediatrics, Medical School, National and Kapodistrian University of Athens, Aghia Sophia Children's Hospital, Athens, Greece
| | - Martin Wabitsch
- Division of Pediatric Endocrinology and Diabetes Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany
| | | | | | - Ljiljana Marina
- Assistant Professor Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
| | - Gudmundur Johannsson
- Institute of Medicine, Sahlgrenska Academy, University of Gothenburg and Department of Endocrinology, Sahlgrenska University Hospital, SE-413 45, Gothenburg, Sweden
| | - E L T Van Den Akker
- Pediatric Endocrinology and Obesity Center CGG, Erasmus MC Sophia Children's Hospital, Rotterdam, the Netherlands.
| |
Collapse
|